BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

BioReference Direct reflects a broader shift toward more accessible, consumer-driven healthcare, where diagnostics play a central role in enabling earlier insights, informed decisions, and ongoing ...
JD Supra

BioReference Laboratories and Parent Company Agree to Pay $9.85 Million to Resolve False Claims Act Violations for Illegal Payments to Referring Physicians

When it comes to the healthcare sector, the Justice Department and the HHS-Office of Inspector General have no shortage of investigations and targets for prosecution. The more resources made available ...
MedCity News

Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million for ...
Nasdaq

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...